Essential thrombocythemia is an uncommon disorder in which your body produces too many blood platelets. This condition may cause you to feel fatigued, lightheaded and to experience headaches and vision changes. It also increases your risk of blood clots.
Essential thrombocythemia (throm-boe-sie-THEE-me-uh) is more common in people over age 50 and slightly more common in women. Young people can develop it as well.
Essential thrombocythemia is a chronic disease that has no cure. If you have a mild form of the disease, you may not need treatment. If you have a severe condition, you may need medicine that lowers your platelet count, blood thinners or both.
June 24, 2015
- Thrombocythemia. Merck Manuals Professional Version. http://www.merckmanuals.com/professional/SearchResults?query=essential+thrombocythemia. Accessed May 11, 2015.
- Tefferi A. Diagnosis and clinical manifestations of essential thrombocythemia. http://www.uptodate.com/home. Accessed May 11, 2015.
- What are thrombocythemia and thrombocytosis? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/thrm. Accessed May 11, 2015.
- Essential thrombocythemia. National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/myeloproliferative/HealthProfessional/page5. Accessed May 11, 2015.
- Tefferi A. Prognosis and treatment of essential thrombocythemia. http://www.uptodate.com/home. Accessed May 11, 2015.
- Myeloproliferative disorders. Lab Tests Online. http://labtestsonline.org/understanding/conditions/myelopro-disorders/start/2. Accessed May 11, 2015.
- Mesa RA (expert opinion). Mayo Clinic, Phoenix/Scottsdale, Ariz. May 16, 2015.
- Stroke: Hope through research. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/stroke/stroke.htm. Accessed May 19, 2015.
- Warning signs of a heart attack. http://www.heart.org/HEARTORG/Conditions/HeartAttack/WarningSignsofaHeartAttack/Warning-Signs-of-a-Heart-Attack_UCM_002039_Article.jsp. Accessed May 12, 2015.
- Chronic myeloproliferative neoplasms treatment. National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/myeloproliferative/Patient/page1/AllPages. Accessed May 13, 2015.